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Neprilysin contributes to free fatty acid (FFA)-induced cellular
dysfunction in nonislet tissues in type 2 diabetes. Here, we show
for the ﬁrst time that with prolonged FFA exposure, islet neprilysin
is upregulated and this is associated with reduced insulin pre-
mRNA and ATP levels, oxidative/nitrative stress, impaired potas-
sium and calcium channel activities, and decreased glucose-
stimulated insulin secretion (GSIS). Genetic ablation of neprilysin
speciﬁcally protects against FFA-induced impairment of calcium
inﬂux and GSIS in vitro and in vivo but does not ameliorate other
FFA-induced defects. Importantly, adenoviral overexpression of
neprilysin in islets cultured without FFA reproduces the defects in
both calcium inﬂux and GSIS, suggesting that upregulation of
neprilysin per se mediates insulin secretory dysfunction and that
the mechanism for protection conferred by neprilysin deletion
involves prevention of reduced calcium inﬂux. Our ﬁndings
highlight the critical nature of calcium signaling for normal insulin
secretion and suggest that interventions to inhibit neprilysin may
improve b-cell function in obese humans with type 2 diabetes.
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F
undamental to development of type 2 diabetes is
failure of b-cells to secrete adequate amounts of
insulin in order to maintain blood glucose levels
within the normal range (1). A common feature
of type 2 diabetes is obesity and concomitantly elevated
free fatty acid (FFA) levels (2). It has long been recognized
that elevated FFAs have differential effects on insulin
secretion depending on duration of exposure; acute ex-
posure leads to increased insulin secretion (3,4), while
chronic exposure impairs insulin secretion and results in
b-cell death (5,6).
Chronically elevated FFAs induce defects at multiple
steps in the pathways governing insulin production and
secretion. As palmitate is a predominant fatty acid in human
plasma and is increased in obese individuals (7), its use in
studies of b-cell function has relevance for human disease.
Studies have shown that palmitate inhibits glucose-induced
insulin promoter activity leading to suppression of insulin
gene expression (8). Key enzymes in glucose and lipid
metabolism are also dysregulated by palmitate exposure
(9), leading to mitochondrial defects such as reduced ATP
production (10) and induction of oxidative/nitrative stress
(11,12). In addition, dysregulated calcium homeostasis
(13,14) and soluble N-ethylmaleimide–sensitive factor at-
tachment protein receptor (SNARE) complex assembly
and/or expression (15,16) due to chronic FFAs have been
reported. Thus, while numerous FFA-induced b-cell defects
have been demonstrated, the critical cellular mediators that
contribute to reduced insulin secretion remain incompletely
deﬁned.
Neprilysin is a widely expressed plasma membrane pro-
tein that in nonislet tissues (e.g., mesenteric fat, endothe-
lium) is upregulated under conditions of elevated FFAs and
has been postulated to mediate cellular dysfunction in type
2 diabetes (17–19). We recently demonstrated that neprily-
sin is synthesized in islets (20) and could therefore play
a role in FFA-induced islet dysfunction. Its normal function
depends on the tissue in which it is located, where it can
exert effects via its dual activities: proteolysis (21) or pro-
tein binding (22–24). Typical functions comprise meta-
bolism of various regulatory peptides of the nervous,
cardiovascular, and immune systems (25). Functions rele-
vant to the islet include involvement in various signaling
pathways including the IGF receptor–Akt cell survival
pathway (23,24,26), degradation of peptides like glucagon
and glucagon-like peptide-1 (27), inhibition of islet amyloid
formation (20,28), and being a component of the renin-
angiotensin system (29,30). The contribution of islet neprilysin
to insulin secretory (dys)function has not previously been
investigated.
Given the central role of the islet in regulating glucose
homeostasis and evidence that upregulation of neprilysin
may be deleterious to cellular function, we sought to deter-
mine whether islet neprilysin contributes to FFA-induced
insulin secretory dysfunction by studying the impact of ne-
prilysin deﬁciency on insulin secretion after chronic expo-
sure to palmitate in vitro and high-fat feeding in vivo.
RESEARCH DESIGN AND METHODS
Breeding pairs of neprilysin-deﬁcient mice on a C57BL/6 background (C57BL/6.
NEP
2/2) were provided by Dr. B. Lu, Department of Pediatrics, Children’s
Hospital, Harvard Medical School, Boston, Massachusetts (31), and a colony was
established both in Seattle, Washington, for in vitro studies and in Melbourne,
Australia, for in vivo studies. Age-matched C57BL/6J wild-type mice from The
Jackson Laboratory were used as controls. For ensuring suitability of C57BL/6J
mice as controls, C57BL/6.NEP
+/+ littermate mice were generated for conﬁr-
matory experiments. Studies were approved by the VA Puget Sound Health Care
System Institutional Animal Care and Use Committee in Seattle and the Austin
Health Animal Ethics Committee in Melbourne.
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ORIGINAL ARTICLEIsletisolationand culture.Islets wereisolatedfrom10-week-oldfemaleandmale
mice as previously described (32). After overnight recovery, islets were tran-
sferred to RPMI media containing 11.1 mmol/L glucose plus either 1 mmol/L
palmitate complexed to BSA in a 5:1 molar ratio or vehicle mixed with fatty
acid–free BSA and cultured for 48 h. For adenovirus studies, freshly isolated
islets were infected with 2.1 3 10
6 pfu/mL (multiplicity of infection = 13)
adenovirus containing either green ﬂuorescent protein (AdV-GFP) (gift from
Dr. C. Rhodes, Department of Medicine, University of Chicago, Chicago, IL)
or neprilysin (AdV-NEP) (gift from Dr. J. Robbins, Molecular Cardiovascular
Biology, Cincinnati Children’s Hospital, Cincinnati, OH) cDNA for 20 h, trans-
ferred to media containing 11.1 mmol/L glucose, and cultured for 48 h. AdV-GFP
and AdV-NEP are similar in construction, prepared using Stratagene’sA d E a s y
system (La Jolla, CA).
Real-time quantitative RT-PCR. Expression of neprilysin mRNA and insulin
pre-mRNA was determined with real-time quantitative RT-PCR using TaqMan
(Mm00485028_m1;AppliedBiosystems,Carlsbad,CA)andSYBRGreen(Euroﬁns
MWG Operon, Huntsville, AL) systems, respectively. TaqMan eukaryotic 18S
rRNA (Hs99999901_s1; Applied Biosystems) was used as endogenous control.
Neprilysin enzymatic activity assay. Islet neprilysin enzyme activity was
determined ﬂuorometrically as previously described (20), with kidney as
a positive control. Brieﬂy, glutaryl-ala-ala-phe-4-methoxy-2-naphthylamine is
broken down by neprilysin in lysates to Phe-4-methoxy-2-naphthylamine and
then the ﬂuorescent product methoxy-2-naphthylamine by aminopeptidase M.
The speciﬁc neprilysin inhibitor DL-thiorphan differentiates neprilysin activity
from nonspeciﬁc endopeptidase activity. Fluorescence is compared against
a methoxy-2-naphthylamine standard curve. C57BL/6.NEP
2/2 islets had un-
detectable neprilysin activity levels (n = 4).
Insulin secretion and content. Insulin secretion in response to 2.8 mmol/L
(basal) or 20 mmol/L (stimulated) glucose was measured in static incubations
as previously described (32). Islet insulin content was measured after acid-
ethanol extraction. Insulin concentrations were determined using the Insulin
(Mouse) Ultrasensitive ELISA (Alpco, Salem, NH).
ATP and nitrate/nitrite levels. Islet ATP levels at 2.8 and 20 mmol/L glucose
were determined as previously described (32) using an ATP bioluminescent
assay kit (Sigma, St. Louis, MO). Forty-eight h conditioned medium was col-
lected and assayed for nitrate and nitrite using a colorimetric kit (Cayman
Chemical, Ann Arbor, MI).
Western blotting. Islet protein separated by SDS-PAGE was transferred to
polyvinylidene ﬂuoride membranes, which were probed with polyclonal rabbit
anti-neprilysin (1:200; Santa Cruz Biotechnology, Santa Cruz, CA) or polyclonal
mouse anti-nitrotyrosine (1:1,000; Millipore, Billerica, MA) antibodies. Stripped
membranes were reprobed with rabbit anti–b-actin (1:2,000; Sigma) antibody
as a loading control. Secondary antibodies were goat anti-rabbit (1:100,000;
Dako, Carpinteria, CA) and goat anti-mouse (1:100,000; Pierce, Rockford, IL)
IgG coupled to horseradish peroxidase.
Rubidium efﬂux. K
+ permeability of islets was measured in static incubations
by monitoring of
86Rb
+ efﬂux. Brieﬂy, islets were incubated for 90 min with
86RbCl (50 mCi/mL), washed four times, and then incubated with 2.8 and 20
mmol/L glucose for 20 min. Incubations with 1 mmol/L glyburide or 500 mmol/L
diazoxide were performed as controls for decreased and increased
86Rb
+ efﬂux,
respectively.
86Rb
+ in supernatant and islet fractions was measured by liquid
scintillation counting and fractional efﬂux calculated.
Calcium inﬂux and imaging. Calcium inﬂuxin the presence of 2.8 or 20mmol/L
glucose was measured as previously described (33). As a control, a subset of islets
was incubated in 20 mmol/L glucose plus the calcium channel blocker nimodipine
(5 mmol/L).
Calciumimaging ofisletsloadedwith4mmol/Lﬂuo-4AMor30mmol/LRhod-3
AM for 30 min and perifused with 2.8 or 20 mmol/L glucose was performed with
a laser-scanning confocal microscope (Zeiss LSM 510 META). Rhod-3 was used
only in adenovirus-infected islets, since ﬂuo-4 overlaps spectrally with GFP.
Changes in intracellular calcium concentrations were measured as changes in
emission intensity at 500–550 nm (ﬂuo-4) or 600–700 nm (Rhod-3) upon exci-
tation with 488-nm (ﬂuo-4) or 561-nm (Rhod-3) lasers. Images were acquired at
10-s intervals, and average ﬂuorescence intensity per islet was calculated using
ImageJ software (NIH Image, Bethesda, MD). As a result of high spatial reso-
lution, confocal imaging allows for detection of calcium levels in individual cells.
Thus, the percentage of cells responding to 20 mmol/L glucose (determined as
an increment in ﬂuorescence above basal) relative to the total number of cells
per islet was computed for an average of 14 islets/condition.
High-fat feeding and in vivo assessments. Ten-week-old C57BL/6.NEP
2/2
and C57BL/6 female and male mice were assigned to receive either standard
rodent chow containing (w/w) 3% fat, 20% protein, and 77% carbohydrate or
high-fat diet containing (w/w) 60% fat, 18% protein, and 22% carbohydrate
(Ridley AgriProducts, Pakenham, Victoria, Australia). After 12 weeks of
feeding, body weights were determined and intravenous glucose (IVGTTs)
(1 g/kg) or intraperitoneal insulin (IPITTs) (0.75 IU/kg) tolerance tests per-
formed with plasma glucose and insulin measured as previously described
(34). No differences were observed in glucose or insulin measures between
female and male mice, and thus data from both sexes were pooled. In a cohort
of nonfasted C57BL/6 mice, plasma was obtained after 8 weeks of feeding for
determination of FFA levels using the Wako NEFA-C kit (Wako Chemicals,
Richmond, VA). At the conclusion of tolerance testing, pancreata were excised
and parafﬁn embedded for histological assessment of insulin and glucagon as
previously described (20).
Statistical analyses. Data are presented as means 6 SEM for the number of
experiments indicated. Statistical signiﬁcance was determined using ANOVA
with post hoc analysis or Mann-Whitney U test if data were not normally
distributed. A P , 0.05 was considered statistically signiﬁcant.
RESULTS
Neprilysin activity is upregulated with chronic palmitate
exposure. We ﬁrst determined whether islet neprilysin levels
are increased with chronic FFA exposure as in other tissues
(18,35). After 48-h culture of C57BL/6 mouse islets in the
absence versus presence of palmitate, neprilysin mRNA (Fig.
1A) and protein (Fig. 1B) levels were unchanged, whereas
neprilysin activity (Fig. 1C) was elevated 1.6-fold.
Neprilysin deﬁciency provides selective protection
against palmitate-induced reductions in glucose-
stimulated insulin secretion. Insulin secretion under
basal conditions (2.8 mmol/L glucose) and in response to
glucose stimulation (20 mmol/L glucose) was assessed
after 48-h culture of islets in the absence and presence of
palmitate (Fig. 2A). In C57BL/6 islets, palmitate exposure
increased basal and decreased glucose-stimulated insulin
secretion (GSIS) as expected. In C57BL/6.NEP
2/2 islets
exposed to palmitate, basal insulin secretion was also in-
creased. In contrast, GSIS was not decreased after chronic
palmitate exposure in C57BL/6.NEP
2/2 islets. This same
pattern of insulin secretion was also observed in cultured
islets from C57BL/6.NEP
+/+ and C57BL/6.NEP
2/2 litter-
mates (Supplementary Fig. 1).
Islet insulin content (Fig. 2B) and pre-mRNA levels (Fig.
2C) were measured and found to be decreased after palmi-
tate exposure in both C57BL/6 and C57BL/6.NEP
2/2 islets,
indicating that protection conferred by neprilysin deﬁciency
was not mediated by preventing palmitate-induced decreases
in insulin biosynthesis but, rather, was selective for GSIS.
Total protein content of islets from C57BL/6 and C57BL/6.
NEP
2/2 mice did not differ (0.20 6 0.02 vs. 0.18 6 0.02 mg
protein/islet for 105 6 7 islets/mouse from 33 mice/geno-
type).
Neprilysin deﬁciency does not protect against palmitate-
induced reductions in ATP levels or production of nitric
oxide and peroxynitrite. For determination of the mecha-
n i s mf o rp r o t e c t i o na g a i n s tr e d u c e dG S I Si nn e p r i l y s i n -
deﬁcient islets, ATP levels were assessed after 48-h cultures
(Fig. 3A). As expected in C57BL/6 and C57BL/6.NEP
2/2 islets
cultured in the absence of palmitate, ATP levels increased
with 20 mmol/L glucose relative to 2.8 mmol/L glucose. In
contrast, C57BL/6 islets exposed to palmitate had signiﬁcantly
reduced ATP levels with 20 mmol/L glucose. Similarly, C57BL/6.
NEP
2/2 islets exposed to palmitate had reduced ATP levels
with 20 mmol/L glucose.
Since FFA-induced oxidative/nitrative stress can adversely
affect b-cell stimulus-secretion coupling (11,12), nitric oxide
and nitrotyrosine (a marker for peroxynitrite) were mea-
sured to determine whether reduced oxidative/nitrative
stress in palmitate cultured C57BL/6.NEP
2/2 islets could
explain the absence of a GSIS defect. Figure 3B shows in-
creased nitrate levels from islets exposed to palmitate, re-
gardless of genotype. Similarly, nitrotyrosine levels assessed
by immunoblotting were elevated in islets exposed to pal-
mitate, regardless of genotype (data not shown).
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in protecting neprilysin-deﬁcient islets from palmitate-
induced insulin secretory dysfunction. As neprilysin has
been suggested to modulate potassium and calcium ion
ﬂux in nonislet tissues (36,37), we investigated whether
neprilysin may play a similar role in islets, thereby me-
diating palmitate-induced defects. Rubidium efﬂux, reﬂecting
K
+ permeability, decreased in response to 20 mmol/L glucose
relative to 2.8 mmol/L glucose in both C57BL/6 and C57BL/6.
NEP
2/2 islets cultured in the absence of palmitate (Fig. 4). In
the presence of palmitate, rubidium efﬂux in response to 20
mmol/L glucose was increased in C57BL/6 and C57BL/6.
NEP
2/2 islets compared with islets cultured in the absence
of palmitate, suggesting that neprilysin’s site of action is
likely distal to the potassium channel. Diazoxide, an opener,
and glyburide, a blocker of KATP channels, were used as
controls for increased and decreased rubidium efﬂux, re-
spectively; no differences were observed between geno-
types (diazoxide with 20 mmol/L glucose, C57BL/6 3.3 6
0.4%
86Rb
+/min vs. C57BL/6.NEP
2/2 2.8 6 0.1%
86Rb
+/min;
glyburide with 2.8 mmol/L glucose, C57BL/6 1.9 6 0.1%
86Rb
+/
min vs. C57BL/6.NEP
2/2 1.9 6 0.1%
86Rb
+/min; n =5 ) .
Inﬂux of radiolabeled calcium (
45Ca
2+) into islet cells
was increased in response to 20 mmol/L glucose relative to
2.8 mmol/L glucose in both C57BL/6 and C57BL/6.NEP
2/2
islets cultured in the absence of palmitate (Fig. 5A). In
C57BL/6 islets cultured in the presence of palmitate,
calcium inﬂux in response to 20 mmol/L glucose was de-
creased. In contrast, in C57BL/6.NEP
2/2 islets cultured in
the presence of palmitate, calcium inﬂux in response to 20
mmol/L glucose remained unchanged compared with islets
in the absence of palmitate. Nimodipine, an L-type calcium
channel blocker, was used as a control in calcium inﬂux
studies. While nimodipine in the presence of 20 mmol/L
glucose blocked calcium inﬂux as expected, no difference
was observed between genotypes (C57BL/6 3.6 6 0.7
pmol/min vs. C57BL/6.NEP
2/2 4.0 6 0.4 pmol/min; n = 5).
For conﬁrmation that neprilysin deﬁciency was indeed
protecting islets exposed to palmitate from reduced
glucose-stimulated calcium inﬂux, the more sensitive and
real-time measure of calcium imaging using ﬂuo-4 was
used. Representative calcium imaging traces (Fig. 5B)
clearly show that C57BL/6.NEP
2/2 islets are protected
from the effects of palmitate exposure to inhibit glucose-
induced calcium inﬂux. Mean data from ﬂuo-4 experiments
are expressed as the proportion of islet cells that respon-
ded (i.e., displayed enhanced ﬂuorescence) to treatment
with 20 mmol/L glucose (Fig. 5C). In C57BL/6 and C57BL/6.
NEP
2/2 islets cultured in the absence of palmitate, 37 and
41% of islet cells, respectively, responded to 20 mmol/L
glucose. In C57BL/6 islets cultured in the presence of
palmitate, only 13% of islet cells responded to 20 mmol/L
glucose. In contrast, in C57BL/6.NEP
2/2 islets cultured in
the presence of palmitate, 31% of islet cells responded to
FIG. 1. Palmitate exposure increases neprilysin activity but not mRNA or protein levels in C57BL/6 islets. Neprilysin mRNA expression (A)( n =
11), protein levels (B)( n = 6; image is a representative blot), and activity (C)( n = 5) in C57BL/6 islets after 48-h culture in the absence or
presence of 1 mmol/L palmitate. Data are means 6 SEM. *P = 0.02 vs. control.
S. ZRAIKA AND ASSOCIATES
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orate the
45Ca
2+ inﬂux data, suggesting that neprilysin is
involved in mediating FFA-induced insulin secretory dys-
function by inhibiting calcium inﬂux.
Upregulation of neprilysin in the absence of palmitate
recapitulates the palmitate-induced impairment of
GSIS. Neprilysin was overexpressed in C57BL/6 islets to
determine whether its upregulation is sufﬁcient to inhibit
calcium inﬂux and reduce GSIS in the absence of palmi-
tate. In AdV-NEP–infected islets, neprilysin protein and
activity levels were increased 5.3 6 1.8-fold and 4.5 6 0.8-
fold, respectively, versus control AdV-GFP–infected islets
(n =4 –6, P , 0.05). Insulin secretion from both AdV-GFP–
and AdV-NEP–infected islets was increased with 20 mmol/L
glucose relative to 2.8 mmol/L glucose (Fig. 6A). However,
in response to 20 mmol/L glucose, AdV-NEP–infected islets
had signiﬁcantly reduced insulin secretion compared with
AdV-GFP–infected islets. Insulin content did not differ
between AdV-GFP– and AdV-NEP–infected islets (Fig. 6B).
Glucose-induced calcium inﬂux was signiﬁcantly reduced
in AdV-NEP–infected versus AdV-GFP–infected islets
(Fig. 6C).
Neprilysin deﬁciency protects against high-fat diet–
induced insulin secretory dysfunction in vivo. High
fat–fed C57BL/6 mice develop impaired GSIS in vivo
(38,39). For determination of whether neprilysin de-
ﬁciency can protect against FFA-induced secretory dys-
function in vivo, C57BL/6 and C57BL/6.NEP
2/2 mice were
fed a low- or high-fat diet for 12 weeks, after which insulin
secretion and sensitivity were assessed by IVGTT and
IPITT, respectively. Body weights (data not shown) and
islet morphology (Supplementary Fig. 2) did not differ af-
ter 12 weeks of feeding regardless of genotype or diet. At 8
weeks, plasma FFA levels were higher in mice fed a high-
versus low-fat diet (1.25 6 0.13 vs. 0.66 6 0.07 mmol/L; n =
10 mice/group, P , 0.001). Despite the unexpected lack of
weight gain, high-fat feeding had the expected effect of
increasing fasting plasma glucose (Fig. 7A) and insulin
(Fig. 7B) levels in both C57BL/6 and C57BL/6.NEP
2/2
mice. During the IVGTT, glucose levels were also elevated
in mice fed a high-fat diet, with absolute levels at each time
point being higher in C57BL/6.NEP
2/2 mice (Fig. 7C).
However, glucose levels declined in parallel so that glucose
tolerance, calculated as the glucose disappearance constant
from 10 to 30 min, was comparable between high fat–fed
C57BL/6 and C57BL/6.NEP
2/2 mice (high fat 0.016 6 0.002
vs. 0.017 6 0.001% per min; low fat 0.018 6 0.001 vs. 0.022 6
0.001% per min). The early insulin response (0–5m i n )t o
glucose was reduced only in high fat–fed C57BL/6 mice
(Fig. 7D). In contrast, the response in C57BL/6.NEP
2/2 mice
FIG. 2. Neprilysin-deﬁcient islets are protected against palmitate-induced reductions in GSIS. Insulin secretion in response to 2.8 and 20 mmol/L
glucose (A)( n = 5), islet insulin content (B)( n = 5), and insulin pre-mRNA levels (C)( n = 9) from C57BL/6 and C57BL/6.NEP
2/2 islets after 48-h
culture in the absence or presence of 1 mmol/L palmitate. White bars, C57BL/6 islets; black bars, C57BL/6.NEP
2/2 islets. Data are means 6 SEM.
*P < 0.05 vs. control; ‡P = 0.0001 vs. C57BL/6.
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terms of the prevailing glucose level (Fig. 7D), remained
unchanged compared with mice fed a low-fat diet. During
the IPITT, glucose levels fell similarly in C57BL/6.NEP
2/2
and C57BL/6 mice, though mice fed a low-fat diet were
more insulin sensitive than mice fed a high-fat diet (Fig. 7E).
DISCUSSION
Chronic elevations in circulating FFAs often accompany
type 2 diabetes (2), and prolonged FFA exposure con-
tributes to b-cell dysfunction (5,6). Neprilysin is a novel
islet protein linked to FFA-induced cellular dysfunction
in other tissues in type 2 diabetes (17). Here, we show for
the ﬁrst time that with prolonged FFA exposure, islet
neprilysin activity is upregulated and this is associated
with b-cell dysfunction. In addition, adenovirus-mediated
overexpression of neprilysin in islets is sufﬁcient to impair
GSIS without exposure to FFAs. Importantly, genetic ab-
lation of neprilysin protects against FFA-induced impair-
ment of GSIS by preventing reduced calcium inﬂux. These
data suggest an important role for neprilysin in mediating
GSIS, speciﬁcally by regulating calcium ﬂux.
In b-cells chronically exposed to elevated FFAs, multiple
defects contribute to increased basal insulin secretion, re-
duced GSIS, and reduced insulin content (40). We now re-
port that palmitate-induced perturbations are associated with
increased neprilysin activity, a ﬁnding documented in other
tissues (18,35). In neprilysin-deﬁcient islets, however, palmi-
tate exposure failed to impair GSIS, suggesting that in-
creased neprilysin activity contributes to palmitate-induced
FIG. 3. Neprilysin-deﬁcient islets exposed to palmitate are not protected against reduced glucose-stimulated ATP levels or nitrative stress. ATP
levels in response to 2.8 and 20 mmol/L glucose stimulation (A)( n = 5) and nitrate/nitrite levels (B)( n = 7) from C57BL/6 and C57BL/6.NEP
2/2
islets after 48-h culture in the absence or presence of 1 mmol/L palmitate. White bars, C57BL/6 islets; black bars, C57BL/6.NEP
2/2 islets. Data are
means 6 SEM. *P < 0.05 vs. control; ‡P < 0.005 vs. 2.8 mmol/L glucose.
FIG. 4. Potassium efﬂux in response to 20 mmol/L glucose stimulation is
similarly elevated in C57BL/6 and neprilysin-deﬁcient islets after pal-
mitate exposure. Rubidium efﬂux, reﬂecting K
+ permeability, in re-
sponse to 2.8 and 20 mmol/L glucose stimulation from C57BL/6 and
C57BL/6.NEP
2/2 islets after 48-h culture in the absence or presence of
1 mmol/L palmitate. White bars, C57BL/6 islets; black bars, C57BL/6.
NEP
2/2 islets. Data are means 6 SEM; n =5 .* P < 0.05 vs. control; ‡P <
0.001 vs. 2.8 mmol/L glucose.
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activity to decreased GSIS, we overexpressed neprilysin in
C57BL/6 islets and assessed secretion after culture in the
absence of palmitate. In line with the effect of palmitate
to increase neprilysin activity and decrease GSIS, over-
expression of neprilysin in the absence of palmitate
reproduced the insulin secretion defect in response to
glucose stimulation. Interestingly, overexpression of
neprilysin did not alter basal insulin secretion or insulin
content compared with islets infected with a control (AdV-
GFP) adenovirus. This is in contrast to C57BL/6 islets
cultured with palmitate, where basal insulin secretion was
elevated and insulin content reduced compared with islets
cultured without palmitate. With respect to this difference
in basal insulin secretion, prolonged exposure to FFAs
causes marked triglyceride deposition that at low glucose
is associated with reduced malonyl-CoA content, an in-
creased rate of fat oxidation (41), and thereby elevated
insulin secretion. Such effects would not be expected in
AdV-NEP–infected islets cultured without palmitate. When
it is also considered that in neprilysin-deﬁcient islets cul-
tured with palmitate basal insulin secretion and insulin
content were not normalized, collectively these ﬁndings
indicate that increased neprilysin activity does not modu-
late basal insulin secretion or insulin content but, rather,
speciﬁcally affects GSIS.
The mechanism by which neprilysin reduces GSIS after
prolonged FFA exposure involves reduced calcium inﬂux,
since in neprilysin-deﬁcient islets all defects except reduced
calcium inﬂux were observed with palmitate exposure, yet
GSIS was not impaired. Further, AdV-NEP–infected islets
cultured in the absence of palmitate showed defects in both
calcium inﬂux and GSIS. Calcium inﬂux through voltage-
gated calcium channels serves as a critical signal to trigger
insulin exocytosis with calcium channel regulation re-
quiring a number of accessory proteins. Neprilysin may play
such a role to modulate calcium inﬂux in b-cells. In fact,
neprilysin has been shown to modulate calcium ﬂux in lung
FIG. 5. Neprilysin-deﬁcient islets exposed to palmitate are protected against reduced glucose-stimulated calcium inﬂux. Calcium inﬂux, measured
using
45Ca
2+, in response to 2.8 and 20 mmol/L glucose stimulation from C57BL/6 and C57BL/6.NEP
2/2 islets after 48-h culture in the absence or
presence of 1 mmol/L palmitate (A)( n = 5). Representative traces for calcium imaging of islets loaded with ﬂuo-4 and perifused with 2.8 mmol/L
and 20 mmol/L glucose (B). Percentage of 20 mmol/L glucose–responsive cells per C57BL/6 or C57BL/6.NEP
2/2 islet after 48-h culture in the
absence or presence of 1 mmol/L palmitate (C)( n =1 1 –14 islets/group), determined as increased ﬂuo-4 emission intensity when the perifusion
solution was switched from 2.8 to 20 mmol/L glucose. White bars, C57BL/6 islets; black bars, C57BL/6.NEP
2/2 islets. Data are means 6 SEM. *P <
0.01 vs. control; ‡P < 0.05 vs. C57BL/6.
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sin inhibition potentiated, calcium ﬂux generated by neu-
ropeptides (36). A similar role for neprilysin in b-cells
would signiﬁcantly impact insulin secretion. Further, the
plasma membrane localization of neprilysin makes its po-
tential interaction with calcium channels and/or accessory
proteins that facilitate calcium inﬂux plausible. Of note,
neprilysin localization may explain why its ablation does
not protect against FFA-induced reductions in insulin pre-
mRNA and ATP levels and oxidative/nitrative stress.
As neprilysin-deﬁcient islets cultured with palmitate did
not exhibit reduced glucose-mediated calcium inﬂux de-
spite reduced ATP levels, KATP channel–independent
mechanisms may be involved in maintaining GSIS. Perhaps
the absence of neprilysin enables a key palmitate-derived
mediator of KATP channel–independent glucose action to
facilitate calcium inﬂux. It is noteworthy that compared
with KATP channel–dependent insulin secretion, the glu-
cose dose response curve for KATP channel–independent
insulin secretion is left shifted (42), suggesting that the
metabolic threshold (including ATP requirements) for se-
cretion is lower. This would ﬁt with the ability of neprily-
sin-deﬁcient islets cultured with palmitate to secrete
comparable levels of insulin upon glucose stimulation rel-
ative to C57BL/6 islets cultured without palmitate, despite
lower ATP levels.
As neprilysin can exert effects via its dual activities—
proteolysis (21) or protein binding (22–24)—it may possibly
either cleave and/or directly bind the cellular component(s),
or perhaps even calcium channel subunits, required for
calcium inﬂux. In support of a proteolytic role, neprilysin is
known to cleave the a-subunit of Na,K-ATPase (37), the
principal pump responsible for restoring equilibrium of Na
+
and K
+ ions across islet cell plasma membranes. A protein-
binding role for islet neprilysin is supported by studies
demonstrating that it directly binds proteins like PTEN (43)
and the p110 subunit of phosphatidylinositol 3-kinase (23),
which are involved in signaling pathways that alter hor-
mone secretion (44,45) and modulate membrane ion chan-
nel activity (46,47). Whether neprilysin exerts a proteolytic
or protein-binding function to mediate b-cell dysfunction
will be the focus of future studies.
To evaluate the signiﬁcance of our in vitro ﬁndings in an
in vivo setting, we studied C57BL/6.NEP
2/2 and C57BL/6
mice after 12 weeks of high-fat feeding. Consistent with
previous studies, C57BL/6 mice developed fasting hyper-
glycemia, fasting hyperinsulinemia, and impaired GSIS
after a high-fat diet (38,39). C57BL/6.NEP
2/2 mice also
developed fasting hyperglycemia and hyperinsulinemia
but, in contrast, did not display reduced GSIS after a high-
fat diet. This latter ﬁnding agrees with the in vitro data
and strengthens the notion that neprilysin may be a critical
mediator of fat-induced insulin secretory dysfunction. What
remains in question, however, is why C57BL/6.NEP
2/2
mice exhibited fasting hyperglycemia despite no defect in
GSIS. One potential explanation may be that since deletion
of neprilysin in C57BL/6.NEP
2/2 mice is global, the ab-
sence of neprilysin in liver and peripheral tissues may be
altering hepatic glucose production and/or peripheral in-
sulin sensitivity, thereby impacting glycemia. That said,
our IPITT data suggest that there is no effect of neprilysin
deﬁciency on whole-body insulin action. While mice fed
a high-fat diet were insulin resistant compared with mice
fed a low-fat diet, insulin sensitivity did not differ between
C57BL/6.NEP
2/2 and C57BL/6 mice. Mice fed a high-fat
diet also had higher glucose levels during the IVGTT, but
glucose disappearance (tolerance) was not affected by
neprilysin deﬁciency. Our ﬁnding that neprilysin deﬁciency
does not confer protection against all fat-induced meta-
bolic defects is consistent with others in the literature
(35,48). Importantly, it is not possible to ascertain whether
other studies involving C57BL/6.NEP
2/2 mice also show
protection against fat-induced reductions in GSIS, since
only glucose but not insulin data are reported. Notwith-
standing, our ﬁndings may be relevant for obese humans
with type 2 diabetes. In fact, a human study showed that
plasma neprilysin activity was positively correlated with
BMI and measures of insulin resistance (35). Taken to-
gether with our ﬁndings, these data would suggest that
inhibition of neprilysin under conditions of chronically
elevated fat could be beneﬁcial.
In summary, we demonstrate that islet neprilysin is
upregulated under conditions of chronically elevated fat,
which contributes to impaired GSIS. While neprilysin
FIG. 6. Adenovirus-mediated upregulation of neprilysin recapitulates the impairment in GSIS and calcium inﬂux due to palmitate exposure. Insulin
secretion in response to 2.8 and 20 mmol/L glucose (A)( n = 8) and islet insulin content (B)( n = 8) from C57BL/6 islets after infection with either
AdV-GFP or AdV-NEP and culture for 48 h in the absence of palmitate. Percentage of 20 mmol/L glucose-responsive cells per AdV-GFP or AdV-NEP
islet after 48-h culture in the absence of 1 mmol/L palmitate (C)( n =1 3 –18 islets/group), determined as increased Rhod-3 emission intensity when
the perifusion solution was switched from 2.8 to 20 mmol/L glucose. White bars, AdV-GFP; black bars, AdV-NEP. Data are means 6 SEM. *P < 0.02
vs. AdV-GFP.
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typically observed with chronic FFA exposure like reduced
ATP levels and oxidative/nitrative stress, it protects against
reductions in calcium inﬂux and impaired GSIS. Our ﬁnd-
ings highlight the critical nature of calcium signaling for
normal insulin secretion and that interventions targeted to
the site of calcium inﬂux, such as neprilysin inhibition, may
improve b-cell function in metabolically altered states.
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